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Abstract
The hyaluronic acid (HA) receptor for endocytosis (HARE) is the primary scavenger receptor for HA and chondroitin sulfates in mammals. The two human isoforms of HARE (full-length 315-kDa and a
190-kDa proteolytic cleavage product), which are type I single-pass
membrane proteins, are highly expressed in sinusoidal endothelial
cells of lymph nodes, liver, and spleen. Their identical HARE cytoplasmic domains contain four candidate AP-2/clathrin-mediated endocytic signaling motifs as follows: YSYFRI2485, FQHF2495, NPLY2519,
and DPF2534 (315-HARE numbering). Stably transfected cells expressing 190-HARE(ΔYSYFRI), 190-HARE(ΔFQHF), or 190-HARE(ΔNPLY)
(lacking Motifs 1, 2, or 3) had decreased 125I-HA endocytosis rates
of ~49, ~39, and ~56%, respectively (relative to wild type). In contrast, 190-HARE(ΔDPF) cells (lacking Motif 4) showed no change in
HA endocytic rate. Deletions of motifs 1 and 2 or of 1, 2, and 4 decreased the rate of HA endocytosis by only ~41%. Endocytosis was
~95% decreased in mutants lacking all four motifs. Cells expressing
a 190-HARE(Y2519A) mutant of the NPLY motif retained 85–90% of
wild type endocytosis, whereas this mutation in the triple motif deletant decreased endocytosis to ~7% of wild type. Tyr in NPLY2519 is
thus important for endocytosis. All HARE mutants showed similar
HA binding and degradation of the internalized HA, indicating that
altering endocytic motifs did not affect ectodomain binding of HA or
targeting of internalized HA to lysosomes. We conclude that, although
NPLY may be the most important motif, it functions together with two
other endocytic motifs; thus three signal sequences (YSYFRI, FQHF,
and NPLY) provide redundancy to mediate coated pit targeting and
endocytosis of HARE.
Abbreviations: GAG, glycosaminoglycan; aa, amino acids; Ab, antibody (IgG); BSA, bovine serum albumin; CD, cytoplasmic domain;
CS, chondroitin sulfate; ECM, extracellular matrix; EV, empty vector; HA, hyaluronic acid, hyaluronate, hyaluronan; HARE, HA receptor for endocytosis; HBSS, Hanks’ balanced salts solution; hHARE, human HARE; M1, HARE CD motif 1 (YSYFRI); M2, HARE CD motif 2
(FQHF); M3, HARE CD motif 3 (NPLY); M4, HARE CD motif 4 (DPF);
PBS, phosphate-buffered saline; TBS, Tris-buffered saline; 190-HARE,
190-kDa HA receptor for endocytosis; 315-HARE, 315-kDa HA receptor for endocytosis; DMEM, Dulbecco’s modified Eagle’s medium;
TEMED, tetramethylethylenediamine; ERK, extracellular signal-regulated kinase; WT, wild type; LDL, low density lipoprotein

The GAGs, which are primarily located at the cell surface
or in the ECM, constitute a polysaccharide family that includes
the chondroitin sulfates, heparin, heparan sulfate, keratan sul-

fate, dermatan sulfate, and HA. HA is found in essentially all
vertebrate tissues, is often a major ECM constituent (,1), and
is abundant in young skin, synovial fluid, vitreous humor of
the eye, and other tissues (e.g. umbilical cord). The size range
of HA (up to ~107 Da) is much greater than other GAGs (<105
Da). Unlike other cell surface receptors for HA, such as CD44
and CD168, HARE mediates the rapid endocytosis of HA via
the clathrin-coated pit pathway (2–4) in an endocytic process
similar to that for transferrin, asialoglycoprotein, mannose
6-phosphate, and low density lipoprotein receptors (5, 6). Although named for its first known function (3), HARE is a general receptor for GAG clearance, mediating the endocytosis of
CS-A, CS-C, CS-D, CS-E, heparin, and dermatan sulfate (CS-B)
(7, 8). Heparan sulfate and keratan sulfate are the only GAGs
that are not ligands for HARE (63).
Despite its simple linear structure (i.e. a polymer of
2-deoxy,2-acetamido-d-glucopyranosyl-β(1,4)-d-glucurono
pyranosyl-β(1,3) disaccharide units), HA is a very dynamic
molecule, whose synthesis and degradation appear tightly
regulated. Mammals degrade and resynthesize about onethird (~5 g) of their total body HA daily. The metabolic halflife of HA varies from ~1.5 day in skin (9) to 2–3 weeks in cartilage (10). Similarly, circulating HA has a half-life of 2–5 min,
because of its rapid clearance by liver sinusoidal endothelial cells (10, 11). In mammals, large native HA (~107 Da) in
ECMs throughout the body is partially degraded to fragments
of ~106 Da that are released into lymphatic fluid and flow to
lymph nodes where sinusoidal endothelial cells remove and
degrade ~85% of the HA. The remaining HA (~15%) passes
through the lymph nodes, enters the blood, and is removed
by the liver via receptor-mediated endocytosis. Although
HA turnover is high, HARE in sinusoidal endothelial cells of
lymph nodes and liver keeps the steady-state HA concentration in blood low (10–100 ng/ml). A high level of HA in the
blood circulation could elevate blood viscosity and impair the
microcirculation in capillaries.
Full-length hHARE is a 2551-aa type I single transmembrane glycoprotein (~315 kDa in SDS-PAGE) encoded by the
180.2-kb STAB-2 gene on chromosome 12q23.3; the gene has
69 exons. HARE proteins were first purified from rat liver (12)
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and human spleen (13). Two isoforms of HARE are present
in tissues (e.g. 190- and 315-kDa hHARE). The smaller HARE
isoform is derived by proteolysis from the full-length protein
(7, 14). Both HARE isoforms are functional membrane receptors that bind and internalize ligands via the clathrin-coated
pit pathway, targeting them to lysosomes for degradation
(2, 4, 7, 8). The 190-HARE (Figure 1A) has a large extracellular domain (1323 aa), a transmembrane domain (21 aa), and
a small (72 aa) COOH-terminal CD (13, 15). The CD (Tyr2480–
Leu2551) contains 17 aa that could be phosphorylated: four
Tyr, seven Ser, one His, and five Thr. Only Ser2497, Ser2537,
Thr2523, Tyr2519, and Tyr2531 are predicted to be phosphorylated (by NetPhos 2.0). The CD does not contain PEST sequences for rapid protein degradation and turnover or for Oglycosylation with GlcNAc.
Endocytic receptors contain either single or multiple targeting sequences that direct the receptor-ligand complexes
into a coated pit pathway (5, 16, 17). There may be multiple
coated pit pathways for internalizing and then creating different microenvironments for different receptor-ligand complexes so they are routed or assemble signaling complexes in
different ways appropriate for the particular receptor (6, 18,
19). In contrast to single motif receptors, the HARE CD contains five putative endocytic motifs (Figure 1 and Table 2):
YSYF2483, YFRI2485, FQHF2495, NPLY2519, and DPF2534. The first
three (YSYF, YFRI, and FQHF) are ΦXXB motifs; where Φ is
either Tyr or Phe, X can be any aa, and B is a hydrophobic aa
with a bulky side chain. The first two sequences are overlapping, located at the junction between the membrane and CD,
and for practical reasons we consider them to be a single motif, YSYFRI2485. The functions of ΦXXB, NPXY, and DP(F/P)
motifs in receptor internalization, trafficking, and delivery of
ligand to lysosomes have been studied extensively in different
receptors (Table 2). Many receptors contain NPXY motifs that
facilitate rapid internalization of receptor-ligand complexes
from the cell surface.
We recently found that HARE is a signaling receptor able
to sense external HA and initiate intracellular activation of the
mitogen-activated protein kinase ERK (64). Thus, we are interested in how HARE is targeted for internalization and intracellular routing. In this study, our goal was to determine which
of the four candidate targeting motifs in the CD of HARE
are important or critical for efficient endocytosis of HA by
the coated pit pathway. The results indicate that three motifs
are important, and thus provide substantial redundancy, for
coated pit targeting and internalization.
Experimental Procedures
Materials and Buffers—Pfu Ultra DNA polymerase for sitedirected mutagenesis was from Stratagene (La Jolla, CA), and
super-competent DH10B-derived Escherichia coli, TOP10 E. coli,
restriction enzymes, cell culture reagents, and hygromycin B
were from Invitrogen. Plasmid DNA was purified using Eppendorf Miniprep (Westbury, NY) or Maxiprep plasmid isolation kits (Promega, Madison, WI). Protease inhibitor mixture
(catalogue P8340) and alkaline phosphatase conjugated to antigoat or anti-mouse polyclonal Abs were from Sigma. Anti-V5
Ab was from Bethyl Labs (Montgomery, TX). Horseradish peroxidase conjugated to anti-goat or anti-mouse polyclonal Abs
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were from Santa Cruz Biotechnology (Santa Cruz, CA). SDS,
Tris, acrylamide, bis-acrylamide, TEMED, ammonium persulfate, high range protein molecular weight markers, p-nitro
blue tetrazolium, and 5-bromo-4-chloro-3-indolyl phosphate
p-toluidine were from Bio-Rad. Solutions for dye binding protein assays (20) and reagents for enhanced chemiluminescence
were from Pierce. Autoradiography film was from Molecular
Technologies (St. Louis, MO). Na 125I was obtained from GE
Healthcare, and 125I-HA was prepared as described previously
(21, 22). Nitrocellulose and polyvinylidene difluoride membrane were from Millipore (Billerica, MA). Unless specified
otherwise, other chemicals and analytical reagent of the highest purity available were from Sigma or Fisher. Growth Medium is DMEM containing 8% (v/v) fetal bovine serum and
100 μg/ml hygromycin B. TBS contains 20 mm Tris-HCl, pH
7.0, and 150 mm NaCl. TBST is TBS with 0.1% (v/v) Tween
20. TBST/BSA is TBST with 1.0% (w/v) BSA. PBS contains
137 mm NaCl 8 mm Na2HPO4 1.5 mm KH2PO4, 2.7 mm KCl,
pH 7.2. HBSS contains 5 mm KCl, 0.4 mm KH2PO4, 0.8 mm
MgSO4, 137 mm NaCl, 0.3 mm Na2HPO4, 5.5 mm glucose,
1.26 mm CaCl2, 0.5 mm MgCl2, and 28 μm phenol red; at the
time of use, 3.5 g/100 ml of NaHCO3 was added, and the pH
was adjusted to 7.2 with HCl. Endocytosis Medium contains
DMEM supplemented with 0.05% (w/v) BSA. Lysis Buffer is
PBS with 0.5% (v/v) Nonidet P-40, 200 μm PMSF, and 1 μg/
ml of protease mixture inhibitor (contains 4-(2-aminoethyl)
benzenesulfonyl fluoride, pepstatin A, E-64, bestatin, leupeptin, and aprotinin).
PCR-assisted Site-directed Mutagenesis—Purified plasmid
DNA (pSecTag/FRT/V5 His-TOPO; Invitrogen) containing
190-HARE cDNA (4248 bp) ligated into the BamHI site was
used as a template to generate the different cDNA mutants
(8). Primers (Table 1) were designed for deletion or site-directed mutagenesis of coding regions for individual and multiple potential endocytic motifs in WT 190-HARE plasmid
DNA. Mutagenesis PCRs were performed for 18 cycles (94 °C
for 20 s, 55–65 °C for 20 s, and 72 °C for 9 min). Parental and
newly generated plasmid DNAs were precipitated with 0.1
volume 3 m potassium acetate, pH 5.5, and 2 volumes of 100%
ethanol. The DNA pellet was dissolved in 17 μl of water and
digested with 5 units of DpnI overnight to eliminate parental DNA. After heat inactivation of DpnI, the DNA solution
was used to transform TOP10 E. coli using standard manufacturer protocols. Bacterial colonies were picked, and potential
190-HARE mutant cDNAs were verified by PCR using genespecific forward (5′-GTTCCATCTACGATCGCCACTGGGCCAG-3′) and vector-specific reverse (5′-CGTAGAATCGAGACCGAGGAG-3′) primers. The complete sequences of the
promoter and complete coding regions of cDNAs in the final
clones were determined to be correct before use in subsequent
experiments. All 190-HARE mutants also contain COOH-terminal V5 and His6 epitopes.
Selection and Characterization of Stable Transfectants—FlpIn 293 cells (60–70% confluent in a 100-mm plate with 10 ml
of fresh DMEM) were transfected with 750 μl of serum-free
DMEM containing 9 μg of pOG44 (which encodes the Flp-In
recombinase), 1 μg of mutant pSecTag-190-HARE, and 20 μl
of Lipofectamine 2000 (Invitrogen). Cells were incubated overnight in Growth Medium without hygromycin B, and then
washed and fed with fresh Growth Medium for the first 3–4
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Table 1. Primer sequences used to create mutations in the 190-HARE CD. Deletion or substitution mutations were made as described under
“Experimental Procedures” using the indicated forward (F) and reverse (R) primers. Deletion of multiple motifs was accomplished by using a
single, double, or triple motif deletion mutant HARE cDNA and a set of primers to delete codons specifying another motif.
190-HARE mutant

Forward and reverse mutagenic primer sequences

(ΔYSYFRI) = ΔM1

F, 5′-GTTGCCTTGGCTGCTAACCGGAGAAC-3′
R, 5′-GATTGTTCTCCGGTTAGCAGCCAAGG-3′
F, 5′-CGGAGAACAATCGGCGAGTCGGAAGAGGAC-3′
R, 5′-GTCCTCTTCCGACTCGCCGATTGTTCTCCG-3′
F, 5′-CAGCAGCCTGAGAATATCTCGGAGAGCACAACCTCAGCTCCC-3′
R, 5′-GGGAGCTGAGGTTGTGCTCTCCGAGATATTCTCAGGCTGCTG-3′
F, 5′-CCAGAACCTTCCTACACGGACTCTGAAGAAC-3′
R, 5′-GTTCTTCAGAGTCCGTGTAGGAAGGTTGCTGG-3′
F, 5′-GAGAATATCTCGAACTTGGCTGAGAGCACAACC-3′
R, 5′-GGTTGTGCTCTCAGCCAAGTTCGAGATATTCTC-3′

(ΔFQHF) = ΔM2
(ΔNPLY) = ΔM3
(ΔDPF) = ΔM4
Y2519A

days and then periodically when required. After 2 weeks, individual isolated colonies were collected and grown in 24-well
plates until confluent. Clones were tested for HARE protein
expression by SDS-PAGE, using 5% gels, followed by Western
blot analysis (23) with anti-V5 Ab. Each clone was also tested
for correct insertion of the mutant pSecTag-190-kDa hHARE
cDNA uniquely into the Flp-In recombination site by the FlpIn recombinase encoded by pOG44, as described previously
(7, 8). At least 4–6 clones of each mutant were selected and
characterized for further experiments.
125I-HA Binding Assays for Cell Surface and Intracellular Receptors—WT 190-HARE, EV, and mutant 190-HARE cell lines
were grown to ~90% confluence in Growth Medium in 12well tissue culture plates. Cultured cells were washed with 1
ml of sterile PBS and 1 ml of serum-free DMEM and were incubated at 37 °C in 1 ml of serum-free medium for 1 h. After
incubation, medium was removed, and the cells were washed
with 2 ml of HBSS and incubated for 2 h at 4 °C in Endocytosis Medium with 1.5 μg/ml 125I-HA with or without a 100fold excess of unlabeled HA to assess nonspecific binding. To
determine total HA binding (by cell surface and intracellular
receptors), cells were permeabilized with 0.055% (w/v) digitonin (24, 25) and incubated with 125I-HA ± unlabeled HA as
above for 2 h at 4 °C. Media were aspirated, and the cells were
washed rapidly three times with HBSS (2 ml per wash) to remove unbound 125I-HA. Cells were then lysed in 1 ml of 0.3 n
NaOH, and radioactivity was measured using a Packard Cobra II gamma counter, and protein was determined by the
method of Bradford (20) using BSA as standard. Data are expressed as fmol/106 cells ± S.E. and normalized for HARE expression relative to WT HARE. Cell number was calculated
based on 398 μg of total protein/106 cells (8). Specific binding
was calculated as binding without unlabeled HA (total) minus
binding in the presence of unlabeled HA (nonspecific). Experiments were performed with each clone in triplicate.
125I-HA Internalization and Degradation Assays—To assess
internalization of 125I-HA, WT 190-HARE, EV, and mutant
HARE cell lines were grown to ~90% confluence, washed, and
incubated in serum-free medium as above. Cells were washed
with 2 ml of HBSS and incubated at 37 °C in Endocytosis Medium containing 1.5 μg/ml 125I-HA with or without a 100-fold
excess of unlabeled HA to assess nonspecific binding, for 2 or
4 h, unless noted otherwise. Medium was aspirated, and cells
were washed three times with HBSS (2 ml each), solubilized

with 1 ml of 0.3 n NaOH, and radioactivity and protein content were determined as above. Specific HA endocytosis or
degradation was calculated as the mean value (as fmol/106
cells/HARE expression relative to WT HARE) without unlabeled HA (total) minus the value in the presence of unlabeled
HA (non-specific). Each experiment was repeated 2–3 times
with multiple clones.
Degradation of internalized 125I-HA was measured using a
cetylpyridinium chloride precipitation assay as described previously (26, 27). Cells were lysed in 0.3 n NaOH, and 100-μl
samples were mixed at 22 °C with 47 μl of 0.6 n HCl, 28 μl
of distilled water, and 125 μl of 2.0 mg/ml HA in 1.5-ml microcentrifuge tubes. Cetylpyridinium chloride (300 μl of 6%;
w/v) in distilled water was added, and the tubes were mixed
by vortexing, and after 10 min, the samples were centrifuged
(22 °C, 5 min, 9000 rpm) in a microcentrifuge, using a swinging bucket rotor. A supernatant sample (300 μl) was taken to
determine radioactivity, and the rest was removed by aspiration. The tube tip containing the precipitated pellet was cut
off and put in a gamma counter tube, and radioactivity was
determined. Degradation values were calculated as the timedependent increase of nonprecipitable radioactivity and are
expressed as the percent (with WT as 100%) of specifically internalized 125I-HA that was degraded.
Western and Ligand Blot Assays—To analyze and normalize
for HARE expression in mutant cell lines, cells at ~90% confluence in 6-well plates were washed twice with cold PBS and
solubilized in Lysis Buffer. Lysates were mixed by vortexing,
incubated on ice for 2 h, and centrifuged at 11,250 × g for 5
min to remove debris. Samples (25 μg of protein) were separated in 5% gels by nonreducing SDS-PAGE, followed by electro-transfer to nitrocellulose membranes for 1 h, 4 °C at 110 V
in 25 mm Tris-HCl, 192 mm glycine, pH 7.4, and 20% (v/v)
methanol. For Western blot analysis of WT and mutant 190HARE protein, membranes were treated with TBST/BSA for 1
h, washed, and incubated with anti-V5Ab for 1 h at 22°C. Blots
were washed three times (5 min each) with TBST/BSA, incubated with goat anti-rabbit Ab conjugated to alkaline phosphatase (or horse-radish peroxidase), washed three times
with TBST/BSA, and incubated with p-nitro blue tetrazolium
and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine-conjugated Ab for color development using alkaline phosphatase.
Reactions were stopped by washing the membrane with distilled water. For horseradish peroxidase detection, membranes
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Table 2. Potential endocytic signals in HARE. The candidate endocytic signals (M1–M4) in the HARE CD, their recognition partners, and potential
functions are summarized. The first motif contains two overlapping YXXΦ motifs as indicated by the sequences that are underlined or in boldface font.
HARE
sequence

Targeting
motif

YSYFRI2485
YXXΦ (ΦXXB)
FQHF2495
ΦXXB
NPLY2519
NPXY
		
DPF2534
DPF/DPW
		

Proposed recognition protein

Function

References

μ subunits of AP complex
μ subunits of AP complex
μ2 subunit of AP-2, Dab2 Tyr(P)
binding domain, clathrin
Ear domain of the α subunit
of AP-2 complex

Internalization, basolateral, or lysosomal targeting
Internalization, basolateral, or lysosomal targeting
Internalization, intracellular, routing/signaling

43, 44, 59–62
43, 44, 59–62
42, 47, 49, 50

Internalization process

34, 35, 37

were incubated with enhanced chemiluminescence substrate
and exposed to autoradiography film. For comparison of 190HARE protein expression levels by mutant cell lines (with
replicates of 4–6 clones per group), HARE band intensities in
Western blots (with equal total cell protein loads) were quantified by densitometry using a FluoroChem8000 Imaging System (Alpha Innotech Corp, San Leandro, CA). Band intensities
were normalized to parallel wild type 190-HARE samples and
expressed as a percent of WT HARE expression.
For ligand blot assays, the post-transfer membranes were
incubated with TBST for 2 h or overnight at 4 °C. To reduce
nonspecifically bound material, and thus background, solutions of 1.5 μg/ml 125I-HA in 10 mm HEPES, pH 7.4, 150 mm
NaCl, 5 mm EDTA, with or without a 100-fold excess of unlabeled HA, were first exposed to unused nitrocellulose at 22
°C for 2 h. The protein-containing membranes were then incubated with the treated 125I-HA solutions for 2 h at 4°C, washed
five times (5 min each) with TBST, air-dried at 22 °C for 30
min, and bound 125I-HA was detected by autoradiography us-

ing Kodak BioMax MS film exposed for 1–15 days at -80 °C.
The same membrane was washed with TBST/BSA and then
probed with anti-V5 Ab to assess HARE expression.
Data Analysis—The assessment of statistical significance for
differences between sample sets, based on three independent
experiments, was by the unpaired Student’s t test.
Results

Whereas many membrane receptors have a single CD sequence that mediates efficient uptake into the coated pit pathway, HARE has multiple candidate motifs for this purpose
(Figure 1A and Table 2). Involvement of multiple motifs might
indicate that redundancy is critical, perhaps for multiple functions of HARE, or that different HARE-ligand complexes
may follow alternative intracellular pathways. To determine
whether any of the four putative endocytic motifs in the HARE
CD are active for targeting to coated pits, we created a panel
of stable Flp-In 293 cell lines expressing 190-HARE mutants
with different endocytic motif deletions or substitution mutations (Figure 1B). Cells expressing mutant 190HARE protein that were negative for
β-galactosidase and sensitive to Zeocin represented the correct insertion
of vector into the single recombinasespecific site in Flp-In 293 cells. We examined multiple clones of the following 190-HARE mutant cell lines
containing single motif deletions
(ΔYSYFRI (ΔM1), ΔFQHF (ΔM2),
ΔNPLY (ΔM3) or ΔDPF (ΔM4)); a
double motif deletion (ΔM1M2), triple motif deletions (ΔM1M2M4)
without and with a Y2519A substitution in M3, and a quadruple motif deletion (ΔM1M2M3M4).
We selected 4–6 individual cell
line clones for each mutant and measured HARE expression in replicates of each group of clones by
SDS-PAGE, Western analysis, and
densitometry using equal amounts of
Figure 1. The 190- and 315-HARE CD and mutants used in this study. A, four putative endototal cell lysate protein as measured
cytic motifs (indicated in boldface and overlined) are present in the 72-aa CD of recombinant 190by the Bradford assay. Although a
2485
2495
HARE (1416 aa long) or 315-HARE (2551 aa long). The four sequence motifs (YSYFRI , FQHF ,
single blot is shown (Figure 2A), the
NPLY2519, and DPF2534) are referred to as M1, M2, M3, and M4, respectively. Numbering is relative
overall results (not shown) demonto the full-length 315-HARE protein (13, 15). V5 and His6 epitopes are at the COOH termini of all
190-HARE mutants. B, scheme illustrates the various motif deletion or site-specific 190-HARE CD
strated that HARE expression within
mutants used. Constructs and stably transfected Flp-In-293 cell lines were prepared as described
each group of mutants was ~85–100%
under “Experimental Procedures.” TM, transmembrane.
of the WT 190-HARE protein level.
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Figure 2. Expression and 125I-HA ligand binding of 190-HARE CD
mutants. Cells were grown to confluence, washed twice with cold
PBS, and centrifuged cell lysates (25 μg of protein) were subjected
to SDS-PAGE and electrotransfer. A, HARE protein was detected by
Western blot analysis using anti-V5 Ab. The 190-HARE proteins are
as follows: lane 1, WT; lane 2, ΔM1; lane 3, ΔM2; lane 4, ΔM3; lane 5,
ΔM4; lane 6, ΔM1M2; lane 7, ΔM1M2M4; lane 8, Y2519A; and lane 9,
EV. B, ligand blot assays were performed with 125I-HA in multiple experiments using different clones of the indicated mutants, and HARE
expression was determined by Western blotting using the same strips
after autoradiography. 125I-HA ligand blot signals were normalized to
HARE expression using densitometry and to WT (as 100%).

Each HARE CD mutant also contains V5 and His6 epitopes at
the COOH terminus. No differences were found in the morphology or cell growth characteristics among the mutant cell
lines, compared with 190-HARE cells (data not shown). Ligand blot assays were performed to quantify specific 125I-HA
binding to the various HARE mutants after SDS-PAGE and
electrotransfer to nitrocellulose (28). Densitometry of autoradiographs followed by Western blot analysis allowed HA
binding to be normalized for HARE protein content, relative
to WT (Figure 2B). All of the HARE CD mutants lacking individual or multiple endocytic motifs bound 125I-HA in ligand
blot assays essentially at WT levels. The HARE CD mutants
also bound comparable amounts of three anti-hHARE mAbs,
compared with WT HARE, indicating there were no changes
in the folding of the mutant HARE ectodomains (not shown).
Typically, endocytic recycling receptors constitutively recycle and are found both on the cell surface and in numerous intracellular compartments, representing different stages of the
receptor routing and recycling pathway. The majority of such
endocytic receptors, including HARE, are intracellular, and
this cellular distribution of receptor molecules reflects the kinetic steady-state of the receptor pathway, which is both kinetic and spatial. If mutation of an important motif sequence
affected the intracellular routing/recycling kinetics of HARE,
then the normal steady-state receptor distribution could also
be altered. To test this, cell lines expressing a variety of 190HARE CD mutants were assessed for cell surface and total (i.e.
cell surface and intracellular receptors in digitonin-permeabilized cells) binding of 125I-HA (Figures 3A and 4A). All 190HARE single mutant cells bound 125I-HA at the cell surface and
to intracellular sites at WT levels (Figure 3A). Among the multiple motif deletion mutants, only the ΔM1/M2/M4 + Y2519A

Figure 3. 125I-HA binding and endocytosis by cells expressing single motif 190-HARE CD mutants. Cells expressing EV, WT, or mutant 190-HARE were incubated in serum-free medium and washed,
and specific 125I-HA binding at 4 °C or endocytosis at 37 °C was quantified as described under “Experimental Procedures.” A, cell surface
and total cellular 125I-HA binding are indicated for cells expressing
190-HARE: WT (white bars), ΔM1 (horizontal rectangles), ΔM2 (diagonal
rectangles), ΔM3 (diagonal lines), or ΔM4 (arrowheads) 190-HARE or EV
(black). Values from 2 to 3 independent experiments are the means ±
S.E. (n = 6–9) specific 125I-HA binding normalized for HARE expression relative to WT 190-HARE. B, specific 125I-HA internalization
was determined at 37 °C for 2 and 4 h as described under “Experimental Procedures.” Values from 2 to 3 independent experiments are
the mean ± S.E. (n = 6–9) specific 125I-HA endocytosis, normalized for
HARE expression relative to WT. The plots show cells expressing WT
(○), ΔM1 (▼), ΔM2 (Δ), ΔM3 (■), or ΔM4 (□) 190-HARE, or EV (•).

HARE mutant displayed significantly less cell surface (p =
0.004) HARE and total (p = 0.02) HARE than WT (Figure 4A).
However, the ΔM1/M2/M4 + Y2519A HARE mutant showed
a surface/internal HARE distribution that was similar to WT.
Thus, all the 190-HARE CD motif-deletion mutants appear to
have normal intracellular receptor trafficking and recycling
kinetics.
To understand the role of putative signal motifs in endocytosis of HA and targeting HARE to coated pits, cells expressing 190-HARE mutants were incubated at 37 °C with 125I-HA
with or without excess HA to assess nonspecific uptake (Figures 3B and 4B). Cells expressing 190-HARE(ΔM4) did not
show any defect in 125I-HA internalization. The specificity of
125I-HA internalization by the WT and all mutant HARE cell
lines was >80%. The rates of 125I-HA internalization by HARE
ΔM1 and ΔM2 mutant cell lines decreased by ~49 and ~39%,
respectively (Figure 3B). Cell lines expressing a double motif
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Figure 5. Degradation of internalized 125I-HA by cells expressing
190-HARE mutants. Confluent cells expressing the indicated WT or
HARE mutants were incubated at 37 °C with 1.5 μg/ml 125I-HA with
or without 150 μg/ml unlabeled HA for 8 h. Medium samples were
taken to assess released 125I-HA degradation products and normalized
as described under “Experimental Procedures.” The values plotted are
the mean ± S.E. (n = 6) percent degradation of the specifically internalized 125I-HA.

Figure 4. 125I-HA binding and endocytosis by cells expressing multiple motif HARE CD mutants. Cells expressing EV, WT 190-HARE,
or 190-HARE mutants were incubated at 37 °C in serum-free medium
for 1 h, washed, incubated, and processed to quantify 125I-HA binding
at 4 °C or endocytosis at 37 °C as described in Figure 3. A, cell surface
and total cellular 125I-HA binding are indicated for cells expressing
EV (black) or 190-HARE: WT (white bars), ΔM1M2 (horizontal rectangles), ΔM1M2M4 (diagonal rectangles), ΔM1M2M3M4 (diagonal lines),
Y2519A (arrowheads), or ΔM1M2M4 + Y2519A (checkerboard). B, endocytosis of 125I-HA by cells expressing 190-HARE: WT (○), ΔM1M2 (▼),
ΔM1M2M4 (Δ), ΔM1M2M3M4 (■), or EV (●). C, endocytosis of 125IHA by cells expressing 190-HARE: WT (○), Y2519A (▼), ΔM1M2M4 +
Y2519A (Δ), ΔM3 (■), or EV (●).

(ΔM1M2) or a triple motif (ΔM1M2M4) deletion showed similar endocytic rate decreases of ~41% (Figure 4B). The essentially identical rates of HA endocytosis by cells expressing
HARE ΔM1M2 or ΔM1M2M4 mutants confirm that the DPF
motif does not play an important role in HARE-mediated endocytosis of 125I-HA. Cells expressing HARE lacking the NPLY
motif (ΔM3) demonstrated ~56% decreased endocytosis rates,

which indicate that this motif is very important, although not
absolutely necessary, for HARE internalization.
After HA is internalized, it is delivered to lysosomes where it
is then degraded by lysosomal hyaluronidase, β-glucuronidase,
and β-N-acetylglucosaminidase (10, 26). 125I-HA degradation
was quantified by a cetylpyridinium chloride precipitation assay (26). No significant differences in the amounts of 125I-HA
degradation were observed for any of the HARE mutants compared with the WT cell lines over 8 h (Figure 5). The results indicate that deletion of different endocytic motifs in the HARE
CD does not affect delivery to and degradation in lysosomes of
the 125I-HA internalized by the various mutants.
To confirm the redundancy of the multiple motifs in the
HARE CD and further assess their role in HARE internalization,
we created additional deletion and point mutation mutants of
M3. Cells expressing a triple motif deletion HARE CD mutant,
Δ(M1M2M4), were compromised in their ability to endocytose
HA but still mediated HA uptake at 58% of the WT 190-HARE
rate (Figure 4B). In contrast, a HARE CD mutant with a single Y2519A change in the NPLY signal sequence showed only
an ~10% reduced rate of HA uptake (Figure 4C); this mutation
had little effect compared with deletion of the whole M3 motif.
However, when the Y2519A mutation was combined with the
triple motif deletion, Δ(M1M2M4), the resulting rate of HAREmediated 125I-HA endocytosis was reduced by ~95% (Figure
4C), to almost the level of background uptake seen in EV cells.
The result shows that in the absence of the functional redundancy provided by motifs M1 and M2, Tyr2519 is critical for the
function of motif M3. Table 3 summarizes the 125I-HA endocytosis rates for all the 190-HARE mutants used in this study.
Discussion
Receptor-mediated endocytosis via the clathrin-coated pit
pathway is a sequential process, involving many cytosolic
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Table 3. Rates of 125I-HA endocytosis by 190-HARE CD variants Cells
expressing the indicated 190-HARE mutants, WT, or EV were assessed
for specific 125I-HA endocytosis and normalized to total protein and
then cell number, and HARE expression relative to WT as described
under “Experimental Procedures.” Values are the mean ± S.E. (n = 6–9).
190-HARE mutant

Specific 125I-HARE
fmol/106

WT
EV
ΔM1
ΔM2
ΔM3
ΔM4
ΔM1M2
ΔM1M2M4
ΔM1M2M3M4
Y2519A
ΔM1M2M3 + Y2519A

cells/WT HARE/h
295 ± 5
0.5 ± 0.3
151 ± 5a,b
180 ± 2b
129 ± 4a
351 ± 6
182 ± 2
172 ± 4
21 ± 3
279 ± 19
14 ± 2

Relative HA uptake
%
100
0.2
51
61
44
119
61
58
7
94
5

a. Data indicate that the rates for the ΔM1 and ΔM3 mutants, compared
with each other, were significantly different; p < 0.002.
b. Data indicate that the rates for ΔM1 and ΔM2 mutants were
significantly different; p < 0.001.

proteins at different steps, in which plasma membrane receptors are specifically and efficiently internalized into the cell.
Based on their interactions with the endocytic cargo (i.e. receptor-ligand complexes), proteins facilitating endocytosis are
classified as accessory or adaptor proteins (e.g. AP-2); >30 different adaptor/accessory proteins may be involved in or control endocytic processes (16, 17, 29). Adaptor proteins bind
to the endocytic cargo and to coat components, thus linking
the two (30). Accessory proteins (e.g. dynamin) are involved
in coated vesicle formation without direct interaction with endocytic cargo (31, 32). Although many other proteins are involved in coat-complex formation, clathrin and adaptor proteins, particularly AP-2, are the major proteins in coated
vesicles (17, 33). Selective recruitment of cargo proteins into
coated pits is mediated by μ2 subunits of AP-2 binding to specific short sequences (3–7 aa) in a receptor CD. These signal sequences are highly, although not exactly, conserved in different organisms, and 2–3 aa of a signal motif are usually crucial
for function. Two major classes of endocytic signal motifs are
predominantly involved in targeting to the coated pit pathway: those that have Tyr as a critical endocytic aa (e.g. NPXY
and YXXΦ) and those with di-Leu (e.g. DEXXX(L/L)I). Accessory proteins implicated in endocytosis process such as Epsin,
(34), Eps15 (35, 36), and Dynamin (37) have DPW or DPF signal sequences that bind the α-adaptin appendage domain.
The 72-aa HARE CD contains four potential signal sequence motifs (YSYFRI2485, FQHF2495, NPLY2519, and DPF2534)
that could be used to target ligand-HARE complexes to the
clathrin-coated pit pathway for rapid endocytosis. As expected, deleting any of these CD motifs had little or no effect
on 125I-HA binding by their respective HARE ectodomains
or on HARE protein expression levels. All HARE mutants
were also recognized by three hHARE-specific mAbs originally raised against rat HARE suggesting that the ecto-domain is not affected by CD mutations (3, 13). However, cells
expressing single or multiple deletions of motifs M1, M2, or
M3 showed very similar (~38–52%) decreases in 125I-HA internalization rates. In contrast, deletion of M4 (DPF2534) did
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not affect 125I-HA endocytosis. Moreover, all of the 190-HARE
CD mutants tested showed no defects in the ability to deliver
the internalized HA to lysosomes, i.e. deletion of different potential endocytic motifs in HARE did not affect the trafficking pathways that deliver internalized HA from plasma membrane to lysosomes. In all but two of the HARE CD mutants,
intracellular receptor routing and recycling appeared to be unaffected. The results do not exclude the possibility that some
of the signal sequences are involved in both coated pit targeting and intracellular routing.
Several classes of endocytic motifs present in the CD of
membrane proteins have been identified that utilize clathrincoated pits for endocytosis. Among these signals, Tyr-containing signal motifs such as YXXΦ and NPXY are the best characterized. Cells expressing 190-HARE(ΔM1) showed slower
125I-HA internalization rates (~49%) compared with WT, indicating that YSYFRI2485, with two overlapping YXXΦ motifs, is
important but not essential for endocytosis. Tyr in the CD of
endocytic recycling receptors (e.g. cation-independent mannose 6-phosphate, asialoglycoprotein, and transferrin receptors (5, 38)) is essential for binding the μ2 subunit of AP-2 and
for accumulation into clathrin-coated pits and rapid internalization (39–41). The dominant signal for β-amyloid precursor
protein endocytosis is also a YXXΦ motif, YENP (42). YXXΦ
motifs are not limited to only endocytic targeting, they can
also help target transmembrane proteins to lysosomes and lysosome-related organelles (43), and sort membrane receptors to
the basolateral plasma membrane of polarized epithelial cells
(44) or to the trans-Golgi network (5, 30, 45).
Tyr is also critical in NPXY endocytic signal motifs, which
are highly conserved from Caenorhabditis elegans and Drosophila melanogaster to mammals, indicating that they participate in
evolutionarily conserved sorting mechanisms. The NPXY signal motifs in other type I integral membrane receptors such
as the LDL receptor, LDL receptor-related protein, integrin β,
and β-amyloid precursor protein mediate rapid endocytosis
via coated pits (42, 46–50). Generally, NPXY signals are found
in medium length CDs (e.g. ~40–200 aa), not closer than 10 aa
from the membrane domain and not present at the very end of
the CD. In hHARE, the NPLY2519 sequence is in the center of
the 72-aa-long CD.
This is the first effort to address the functional roles of
YXXΦ, DPX, and NPXY motifs in the endocytosis of hHAREligand complexes. The hHARE CD actually has three ΦXXB
motifs: the overlapping YSYF and YFRI sequences in M1 and
the M3 motif FXXF2495. Interestingly, the rat HARE CD has corresponding and nearly identical YSYFRL (M1) and FQRF (M2)
sequences but does not contain DP(F/W) or NPXY motifs (13,
14). Our results indicate that although NPLY2519 (M3) is slightly
more important for endocytosis by hHARE, the YSYFRI2485
(M1) and FQHF2495 (M2) sequences also contribute substantially to the overall internalization of HA. Thus, no single motif was critical for rapid uptake of HARE, and the three motifs
provide, for as yet unknown reasons, unexpected redundancy
for internalization. Redundancy may be needed for functions
of HARE other than just GAG clearance. One newly discovered
function is the recent finding that HARE is a signaling receptor that mediates intracellular activation of ERK1 and -2, in response to the concentration of external HA (64). Perhaps one of
the three active endocytic signal sequences is also specifically
involved in activation of the ERK signaling pathway.
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Some receptors have a single signal motif for internalization. For example, substitution of Tyr807 with Cys or Ala reduces endocytosis by ~85% in the LDL receptor, whereas substitution with Phe does not abolish rapid internalization. An
NPXY motif in the insulin-like growth factor I receptor is the
primary motif for internalization and is also involved in the
signaling pathway (51). Other receptors possess multiple motifs for internalization, so that mutation or deletion of a single motif often does not completely abolish receptor internalization. For example, two NPXY motifs in integrin β1 are
required for recruitment to focal adhesions (52), and the CD
of megalin has two NPXY motifs that are both important for
coated pit targeting (53). The interleukin-13 receptor α2 contains a diLeu- and a Tyr-based endocytic motif, and substitution or deletion of either motif decreases endocytosis of 125Iinterleukin-13 by ~50%, indicating that both endocytic motifs
work together for internalization (54). In some proteins, endocytic motifs are not involved in endocytosis and therefore
not signal sequences. The angiotensin II receptor contains four
candidate Tyr-based motifs and one diLeu-based motif, but
only Tyr319 and LL316 are important for efficient receptor internalization (55). The CD of the receptor for LDL-related protein
1 contains one YXXΦ, two NPXY, and two diLeu motifs. However, only the YXXΦ and one diLeu are dominant endocytic
signals for targeting receptor to coated pits (56).
It may not be surprising that multiple endocytic motifs
are involved in HARE-mediated internalization of 125I-HA.
Although we have characterized HARE most extensively
as an HA receptor, it also specifically binds and internalizes many other ligands. In addition to HA and multiple CS
types, HARE/Stabilin 2 specifically recognizes advanced glycation end products (e.g. AGE-BSA) and acetylated-LDL (57),
which we have confirmed. We also recently discovered that
the 190-HARE and 315-HARE proteins are endocytic receptors
for heparin (63). Thus, HARE binds and internalizes sulfated
(CS, DS, and heparin) and nonsulfated (HA and chondroitin) GAGs and advanced glycation end products. Nonetheless, HARE is specific and does not simply bind any anionic
polymer, because heparan sulfate, keratan sulfate, polygalacturonic acid, and nucleic acids are not ligands (2, 7, 8, 58).
In summary, the results show that NPLY2519 is a slightly
more active endocytic signal sequence in the CD of 190-HARE
than YSYFRI2485 or FQHF2495. In contrast, deletion of the
DPF2534 sequence motif did not affect endocytosis. Thus, the
maximum rate of HARE endocytosis requires that the three
endocytic motifs (YSYFRI, FQHF, and NPLY) work together
for efficient coated pit targeting and endocytosis of HARE.
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